ICD—dr3
CW-W, “ﬁr/“'6”?
MIA/I NJ! Vida/3
.ﬁﬂ. 64:44: w; 631,?

//-w/// /«/

 
  

  

Diagram
“—
Tumor Sin.-

 
 
 

Procedure Date:
Procedure Physician:
Attending Physician/Copies To:

 
 
 

Jrior

   

Case is

      
 
 

lmtiels "EVIGWPII:

FEW—#4? _ ,

UUID : FA86A743-EA67-4554-ABA2-BBEC1DBDBOBI

 

PATIENT HISTORY: TceA-sH-Msx-mA-PR Redacted
SPECIMENS TAKE“ BY PAT“ Dtml °¢ LHP= (NOT LISTED 0“ REQUISITION) HIHHIHHHIHHHIHHIHHIHHIHHllﬂlmlﬂlﬂﬂﬂﬂﬂlﬂ
32:503'n§2§§o§§§fv§?2§r éaaAST CANCER IHIHHIHHHHIHHIHHHIHHHIHIIHlﬂﬂﬂlﬂﬂﬂlﬂ
POST-OP niesuoszs: 3AM; mIHHHHHIHHHHHHIHHHIMIHHHIHHHHHHIHHI

OPIRATIVE PROCEDURE: R SENTINEL LYMPH NODE, R SEGMENTAL MASTECTOMY

CLINICAL HISTORY: SPECIMENS TAKEN BY PATH

MATERIAL SUSHIT‘IID: A) RIGHT SENTINEL LYMPH “ODE, PROCUREMENT BY SURGICAL PROCEDURE

B) RIGHT BREAST BIOPSY/TISSUE, PROCUREMENT BY SURGICAL PROCEDURE

long-lat,med-med,sht—superior

memuve CONSULTATIODI: E SENTINEL LYMPH MODE *1: One lymph node, 0.8 by 0.6 by 0.5 cm. Touch Prep
Diagnosis: Negative. “ .

 

ADDENDA: '

Addendum
FISH anelyeie using DNA probe for Her-Zineu gene showed that. the ratio of Her-Zineu eignele to chromosome 17
centromere eignele is 0.94 (g 2.0 ratio ie considered ampliﬁed). Therefore, Her-Zlneu gene is not amplified.

    
 
  

Patholu . . , , .
" Report El . (zlageevurz«;<'-i2’=*-“- .: .
JV ”cinch" -

My signature is attestation that i have penonelly reviewed the submitted materiel“) end the above diegnoeie reflects that evaluation.

Addggdum

MATERIAL SMTTBD: BLOCK "B3" FOR ER/PR AND HER-ZINEU (BREAST CANCER)
FINAL DWOSIS:

BBTROGZN/PROGIS'IIRONH RECEPTORS AND HIR-2/NIU 93mm» 0!! BIG!!! BREAST 118m

ESTROGEN RECEPTOR (0- 40‘; 1* 40‘: 2+ 10%; 3+ 10%) HSCORS Ol' 90. ESTROGEN ““9708 IS IWTED A8
POSITIVI

PROGISTIRO‘NI RECEPTOR (O- 70%: 1+ 10‘; 2+ 10%; 3+ 10‘) HSCORI 0' 60. 230628209!!! RECEPTOR IS manure: AB
' POSITIVE

nea—z/m—mm HERCEPTIST. A WEAK 1'0 mute (INLET! m STAINING 18 OBSERVED IN none THAN 101 OF THE
TUMOR cums. HER-ZINE!) I! INTERPRETED AS POCITIVE (SCORE 2+)

Hscou: <- 15 NEGATIVE ' ’
>15<=3o BORDERLINI \

FINAL DIAGNOSIS: \

FINAL omosxs:
“he

 

A) RIGHT SMI‘N’I‘L LMH NOD! .1:

- MICRMTASTATIC DUCTAL mm 0! THE BREAST (SEE NOTE!

B) 3E6“ SEWAL mnc'rom: '

-<IRPILTR§TING neonate; nrmmgmﬂoucm mum} mum scone 6(9 surname-3, wcuz=2l
241335151). 513: 2.5 or 2.0 u 1.5 cu

- DUCI'AL CARCINM IN 8111] non-compo '1'!PI, SOLID AND mmmlggﬁnucxm GRAD] 1L CONSTIIUTIS 5" 0! mm:
TUMOR MASS
- smut. MICROSCOPIC £001 0? INFILTRATING QinOCARCINM, UP T0 0.5 01L 1!! TEWING BREAST 1133115406,
'9‘ I122
- mum AND INFERIOR SURGICAL MARGINS POSITIVE FOR INVASIVI TUMOR
- INTRADUCTAL PHIL“ MID PROLIFERAIM IIBROCYS'IIC CHANGI' IN Till WING BREAST T1330!
- FOCAL NECEIOSIS AND GRANULATION TISSUE, STATUS-POST COR] BIOPSY Ol' ems-r (CROSS REFER
NOTE: Minute cluetere of metastatic ductel carcinome wee round in aerial notion "A1", but it ie beet
visualized with the immunopezoxideee stain All/A33 in eerie]. eection AZ. The inmate-tail: wee repeated and
the presence of metastatic neoplastic cone in the lymph node eection "A1" as: tree continued by ‘
immunoetaining ("new") . The late: aetiel eeotione of. the lymph nodee are negative. The touch prep of the
sentinel node wee ze- reviewed and no malignant cell- ue identified. Int/PR immopetoxideee eeeey end He:-
2/NIU teetinq will be pettormed on block "33".
The special eteine end/o: imoperoxideee teete need in thi- nee Hw- I'm-'- Ann-1M and their performance
ohuecterietice determined by the Department: of Pathology at

. They have not been cleared 0: approved by tile 11.9. Food end Drug Adminietzetion.

 

